MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$10.00 0.50 (5.26%)
Open Price: 9.38
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients